Clinical trial design issues in the era of targeted therapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15217975.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although our lack of effective therapies mandates the development of new, molecularly targeted therapies, a number of issues in the design of clinical trials and their end points remain to be considered.
Medical subject headings
- Clinical Trials as Topic
- Drug Design
- Research Design